In its Q4 2025 letter, David Einhorn's Greenlight Capital revealed a new position in Antero Resources (AR), signaling a strategic move into the natural gas sector. The hedge fund's portfolio returned 8.5% for the quarter, outpacing the S&P 500.
In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
The AI-as-a-Service (AIaaS) market is witnessing significant growth, fueled by cloud innovation and corporate demand for scalable AI solutions. While data privacy remains a hurdle, the integration of generative AI and tailored platforms is accelerating adoption across industries.
Newly launched oral weight-loss drug Wegovy from Novo Nordisk recorded more than 26,000 U.S. prescriptions in its second full week, signaling robust early demand as competition with Eli Lilly intensifies.
Consumer staples giant Church & Dwight (NYSE:CHD) reported fourth-quarter revenue in line with Wall Street expectations, though underlying organic sales showed signs of stagnation. The company's gross margin outperformance provided a bright spot, lifting shares post-earnings.
Goldman Sachs downgrades iHeartMedia to Sell, warning that shifting audio consumption and ad trends threaten growth, even as the company's TikTok partnership aims to capture younger audiences.
A detailed Discounted Cash Flow analysis suggests Eagle Eye Solutions Group (LON:EYE) shares are trading close to their estimated intrinsic value. We examine the assumptions behind the numbers and what investors should consider beyond the model.
Despite a cautious 'Moderate Sell' consensus, Paramount Skydance (PSKY) carries an average price target of $14.08, implying significant potential upside. The media giant's recent Q3 2025 results highlighted robust Paramount+ subscriber growth, even as investors weigh heavy content investments and integration risks.
Fresh Israeli military actions in central and southern Gaza have resulted in multiple casualties, testing the durability of a months-long, U.S.-brokered truce and hindering critical aid flows.
Shares of NCR Voyix (VYX) saw a modest uptick this week, yet the broader picture remains challenging. With a significant decline over the past year and a net loss reported on substantial revenue, investors are questioning if the current valuation gap represents a genuine opportunity or a reflection of deeper issues.
Endeavour Silver's 2026 production guidance signals a strategic shift, with the new Kolpa mine set to deliver significant lead, zinc, and copper output. This diversification beyond precious metals aims to stabilize revenue, but execution risks and funding challenges remain key hurdles for the TSX-listed miner.
Following a rupture in their longstanding security alliance, French President Emmanuel Macron and Chadian leader Mahamat Idriss Deby Itno have agreed to reset bilateral relations, placing future cooperation squarely in the economic and developmental sphere.
While major indices tread water ahead of key earnings, a segment of the market continues to buzz with activity. We examine three micro-cap companies—Hongli Group, Royalty Management, and CreateAI—whose financial profiles and strategic moves are capturing attention from investors willing to navigate the high-risk, high-reward penny stock arena.
Meta Platforms delivered a stronger-than-expected quarter, fueled by robust advertising revenue and user growth. However, the company's sharply rising expense forecasts for AI and infrastructure investments are drawing increased analyst attention.
AEW UK REIT plc (LON:AEWU) is overwhelmingly owned by institutional investors, a sign of significant confidence but also concentrated influence. We examine the ownership structure and what it means for the £170m property trust.
The long-term strategic partnership will leverage IQVIA's data-as-a-service platform to unify and streamline commercial data across 59 countries, aiming to accelerate product launches and enhance decision-making for the pharmaceutical giant.
President Donald Trump announced his intent to nominate Kevin Warsh, a former Federal Reserve governor and longtime critic of current policy, as the next Fed chair. The move, seen as an effort to align the central bank more closely with White House priorities, could redefine its historic independence and monetary policy direction.
Israeli authorities announce the reopening of the Rafah crossing this Sunday, ending a nearly two-year blockade of Gaza's sole passage to Egypt.
With major indices treading water after the Fed's steady rates, savvy investors are turning to overlooked small-cap stocks where insider buying signals conviction. We examine three companies where executives are backing their firms with their own capital.
Former President Trump claims tariff revenue can fund direct payments to Americans, bypassing Congress. Experts question the legality and economic feasibility of the proposal.
